Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
申请人:BEECHAM GROUP PLC
公开号:EP0068669A1
公开(公告)日:1983-01-05
Compounds of formula (I)
and salts and in vivo hydrolysable acyl derivatives thereof wherein
R' is hydrogen or methyl;
R2 is hydrogen or methyl;
R3 is hydrogen, fluarine, chlorine, bromine, trifluoromethyl or C1-6 straight or branched chain alkyl;
R4 is nitro,
or optionally substitutec
RS is hydrogen or C1-6 straight or branched chain alkyl;
X is R6;
R6 is hydrogen or C1-6 straight or branched chain alkyl;
R7 is C1-6 straight or branched chain alkyl;
R8 is hydrogen or C1-6 straight or branched chain alkyl;
m is an integer from 1 to 6;
p is an integer from 2 to 5;
q is an integer from 0 to 2;
provided that p + q is from 3 to 5;
Y is
R9 is hydrogen, C1-6 straight or branched alkyl or aralkyl consisting of a C2 or C10 aryl group and a C1-6 straight or branched chain alkylene group;
any substituent on the
group when present, being a carboxyl group or a salt, ester or amide thereof.
have anti-obesity, and/or hypoglycaemic and/or antiin- flammation and/or platelet aggregation inhibiting activity.
式(I)化合物
及其盐类和体内可水解酰基衍生物,其中
R' 是氢或甲基
R2 是氢或甲基
R3 是氢、氟、氯、溴、三氟甲基或 C1-6 直链或支链烷基;
R4 是硝基、
或任选取代的C
RS 是氢或 C1-6 直链或支链烷基;
X 是 R6;
R6 是氢或 C1-6 直链或支链烷基
R7 是 C1-6 直链或支链烷基
R8 是氢或 C1-6 直链或支链烷基;
m 是 1 至 6 的整数;
p 是 2 至 5 的整数
q 是 0 至 2 的整数;
条件是 p+q 为 3 至 5;
Y 是
R9 是氢、C1-6 直链或支链烷基或由 C2 或 C10 芳基和 C1-6 直链或支链亚烷基组成的芳基;
基团上的任何取代基
基团上的任何取代基均为羧基或其盐、酯或酰胺。
具有抗肥胖和/或降血糖和/或抗炎和/或抑制血小板聚集活性。